antibodies against p atm (Cell Signaling Technology Inc)

Cell Signaling Technology Inc is a verified supplier

Cell Signaling Technology Inc manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Cell Signaling Technology Inc antibodies against p atm
Antibodies Against P Atm, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+atm/pmc13011042-69-21-25
Average 86 stars, based on 1 article reviews

antibodies against p atm - by Bioz Stars, 2026-09

86/100 stars

Images

other:

Article Title: HP1β recruits RING1A to ubiquitinate histone H2A for BRCA1-mediated resection of double-stand breaks
Article Snippet: Anti- ATM , Cell signaling , Cat#2873.

Article Title: Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme
Article Snippet: Anti-ABCG2 (cat# ab3380), MGMT (Cat# Mab16200), Antibodies against N-cad (Anti-N-Cadherin, #4061), Anti-mTOR #2972), phospho-mTOR (Rabbit mAb #5536), Anti-EGFR (Rabbit mAb #4267), and Anti-ATM (Rabbit mAb #2873), were obtained from Cell Signaling Technology.

Article Title: RUVBL1 and RUVBL2 are druggable MYC effector regulators in neuroblastoma cells
Article Snippet: Anti-ATM (host rabbit) , Cell Signaling Technology , RRID: AB_2062659.

Article Title: Aptamer-functionalized exosomes combined with doxorubicin suppress GBM progression and enhance chemoradiosensitivity by promoting pyroptosis
Article Snippet: The following primary antibodies were used under conditions specified by the manufacturers’ protocols: anti-GAPDH (Sigma, AF0911, 1:2000), anti-β-actin (Boster, BM0627, 1:2000), anti-53BP1 (CST, 4937, 1:500), anti-pATM (Ser1981) (CST, 5883, 1:500), anti-ATM (CST, 2873, 1:1000), anti-EGFR (CST, 4267, 1:1000), anti-pEGFR (tyr1038) (CST, 3777, 1:1000), anti-pChk2 (T68) (CST, 2661, 1:500), anti-Chk2 (CST, 2662, 1:500), anti-pH2A.X (S139) (CST, 9718, 1:1000), anti-cleaved-caspase-1 (tyr1038) (GeneTex, GTX133447, 1:500), anti-GSDMD (Abcam, AB210070 , 1:1000), anti-N-GSDMD (ABclonal, A22523, 1:500), anti-caspase-1 (Abcam, AB207802 , 1:1000), anti-NLRP3 (ABclonal, A5652, 1:1000), anti-caspase-3 (abcam, ab32351, 1:2000), anti-GSDME (abcam, ab215191, 1:2000), anti-CD63 (Abcam, AB217345 , 1:1000), anti-TSG101 (Abcam, AB125001 , 1:5000), anti-calnexin (Abcam, ab22595, 1:1000), and anti-CD81 (Santa Cruz Biotechnology, BS70675, 1:500).

Article Title: Dihydroartemisinin enhances NKG2D CAR-T cell therapy against solid tumors by inducing NKG2D ligands and remodeling the tumor microenvironment.
Article Snippet: The following antibodies were used: anti-ATM, anti-p53 and anti-Akt were sourced from Cell Signaling Technology, CST (USA), anti-GAPDH was obtained from Santa Cruz (USA).

Western Blot:

Article Title: Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer.
Article Snippet: .. The following antibodies were used for western blot analysis: anti-p-ATR (S428) (1:1000; 2853, Cell Signaling Technology, MA, USA), anti-ATR (1:1000; 13934, Cell Signaling Technology), anti-p-CHK1 (S345) (1:1000; 2348, Cell Signaling Technology), anti-CHK1 (1:1000; ab40866, Abcam, Cambridge, UK), anti-ATRIP (1:1000; 2737, Cell Signaling Technology), anti-p-ATM (S1981) (1:1000; 13050, Cell Signaling Technology), anti-ATM (1:1000; 2873, Cell Signaling Technology), anti-p-CHK2 (T68) (1:1000; 2197, Cell Signaling Technology), anti-CHK2 (1:1000; 6334, Cell Signaling Technology), anti-γ-H2AX (1:5000; AP0687, ABclonal, Wuhan, China), anti-β-actin (1:4000; A5316, Sigma-Aldrich). .. The following antibodies were used for IF analysis: anti-p-ATR (S428) (1:100; AP0676, ABclonal), anti-ATR (1:200; ab313435, Abcam), anti-pCHK1 (S345) (1:50; 2348, Cell Signaling Technology), anti-CHK1 (1:200; ab40866, Abcam), anti-γ-H2AX (1:50; AP0687, ABclonal).

Article Title: Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer
Article Snippet: .. The following antibodies were used for western blot analysis: anti-p-ATR (S428) (1:1000; 2853, Cell Signaling Technology, MA, USA), anti-ATR (1:1000; 13934, Cell Signaling Technology), anti-p-CHK1 (S345) (1:1000; 2348, Cell Signaling Technology), anti-CHK1 (1:1000; ab40866, Abcam, Cambridge, UK), anti-ATRIP (1:1000; 2737, Cell Signaling Technology), anti-p-ATM (S1981) (1:1000; 13050, Cell Signaling Technology), anti-ATM (1:1000; 2873, Cell Signaling Technology), anti-p-CHK2 (T68) (1:1000; 2197, Cell Signaling Technology), anti-CHK2 (1:1000; 6334, Cell Signaling Technology), anti-γ-H2AX (1:5000; AP0687, ABclonal, Wuhan, China), anti-β-actin (1:4000; A5316, Sigma-Aldrich). .. The following antibodies were used for IF analysis: anti-p-ATR (S428) (1:100; AP0676, ABclonal), anti-ATR (1:200; ab313435, Abcam), anti-p-CHK1 (S345) (1:50; 2348, Cell Signaling Technology), anti-CHK1 (1:200; ab40866, Abcam), anti-γ-H2AX (1:50; AP0687, ABclonal).

Article Title: M1C Mediates LINE-1 Transcription in PARP Inhibitor-Treated Prostate Cancer Cells.
Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article.

Review

antibodies against p atm (Cell Signaling Technology Inc)

Structured Review

Images

Related Articles

other:

Western Blot:

Similar Products

Image Search Results